Can transcriptomics cut the Gordian knot of amyotrophic lateral sclerosis?

Current Genomics

Volumn 12, Issue 7, 2011, Pages 506-515

  Henriques, Alexandre ^a,b   de Aguilar, Jose Luis Gonzalez ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Amyotrophic lateral sclerosis; Biomarker; Pathogenesis; Transcriptomics

Indexed keywords

BIOLOGICAL MARKER; DYNACTIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; RNA; TOLL LIKE RECEPTOR 4;

AMYOTROPHIC LATERAL SCLEROSIS; CYTOLOGY; DISEASE COURSE; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSDUCTION; GENETIC VARIABILITY; HUMAN; LIPID METABOLISM; MUSCLE BIOPSY; NONHUMAN; PATHOGENESIS; PROGNOSIS; REVIEW; RNA PROCESSING; RNA TRANSLATION; TRANSCRIPTOMICS; TRANSGENIC RAT;

ANIMALIA; GORDIA;

EID: 80055120753     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/138920211797904043     Document Type: Review

References (76)

1. Mitchell, J. D.; Borasio, G. D. Amyotrophic lateral sclerosis. Lancet, 2007, 369, 2031-2041.
2. Boillee, S.; Vande Velde, C.; Cleveland, D. W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 2006, 52, 39-59.
3. Cheah, B. C.; Vucic, S.; Krishnan, A. V.; Kiernan, M. C. Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr. Med. Chem., 2010, 17, 1942-199.
4. Rosen, D. R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 1993, 364, 362.
5. Sreedharan, J.; Blair, I. P.; Tripathi, V. B.; Hu, X.; Vance, C.; Rogelj, B.; Ackerley, S.; Durnall, J. C.; Williams, K. L.; Buratti, E.; Baralle, F.; de Belleroche, J.; Mitchell, J. D.; Leigh, P. N.; Al-Chalabi, A.; Miller, C. C.; Nicholson, G.; Shaw, C. E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science, 2008, 319, 1668-1672.
6. Kwiatkowski, T. J., Jr.; Bosco, D. A.; Leclerc, A. L.; Tamrazian, E.; Vanderburg, C. R.; Russ, C.; Davis, A.; Gilchrist, J.; Kasarskis, E. J.; Munsat, T.; Valdmanis, P.; Rouleau, G. A.; Hosler, B. A.; Cortelli, P.; de Jong, P. J.; Yoshinaga, Y.; Haines, J. L.; Pericak-Vance, M. A.; Yan, J.; Ticozzi, N.; Siddique, T.; McKenna-Yasek, D.; Sapp, P. C.; Horvitz, H. R.; Landers, J. E.; Brown, R. H., Jr. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science, 2009, 323, 1205-1208.
7. Neumann, M.; Kwong, L. K.; Sampathu, D. M.; Trojanowski, J. Q.; Lee, V. M. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch. Neurol., 2007, 64, 1388-1394.
8. Dupuis, L.; di Scala, F.; Rene, F.; de Tapia, M.; Oudart, H.; Pradat, P. F.; Meininger, V.; Loeffler, J. P. Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis. FASEB J., 2003, 17, 2091-2093.
9. Halter, B.; Gonzalez de Aguilar, J. L.; Rene, F.; Petri, S.; Fricker, B.; Echaniz-Laguna, A.; Dupuis, L.; Larmet, Y.; Loeffler, J. P. Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis. Free Radic. Biol. Med., 2010, 48, 915-923.
10. van Blitterswijk, M.; Landers, J. E. RNA processing pathways in amyotrophic lateral sclerosis. Neurogenetics, 2010, 11, 275-290.
11. Dupuis, L.; Pradat, P. F.; Ludolph, A. C.; Loeffler, J. P. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol., 2011, 10, 75-82.
12. De Vos, K. J.; Chapman, A. L.; Tennant, M. E.; Manser, C.; Tudor, E. L.; Lau, K. F.; Brownlees, J.; Ackerley, S.; Shaw, P. J.; McLoughlin, D. M.; Shaw, C. E.; Leigh, P. N.; Miller, C. C.; Grierson, A. J. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet., 2007, 16, 2720-2728.
13. Bogaert, E.; d'Ydewalle, C.; Van Den Bosch, L. Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target. CNS Neurol. Disord. Drug Targets, 2010, 9, 297-304.
14. Janik, P.; Kwiecinski, H.; Sokolowska, B.; Niebroj-Dobosz, I. Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. J. Neural Transm., 2010, 117, 343-347.
15. Philips, T.; Robberecht, W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol., 2011, 10, 253-263.
16. Garbuzova-Davis, S.; Saporta, S.; Haller, E.; Kolomey, I.; Bennett, S. P.; Potter, H.; Sanberg, P. R. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One, 2007, 2, e1205.
17. Boillee, S.; Yamanaka, K.; Lobsiger, C. S.; Copeland, N. G.; Jenkins, N. A.; Kassiotis, G.; Kollias, G.; Cleveland, D. W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science, 2006, 312, 1389-1392.
18. Dupuis, L.; Oudart, H.; Rene, F.; Gonzalez de Aguilar, J. L.; Loeffler, J. P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. USA, 2004, 101, 11159-11164.
19. Brooks, B. R.; Miller, R. G.; Swash, M.; Munsat, T. L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord., 2000, 1, 293-299.
20. Kraemer, M.; Buerger, M.; Berlit, P. Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Clin. Neurol. Neurosurg., 2010, 112, 103-105.
21. Zhou, J. Y.; Afjehi-Sadat, L.; Asress, S.; Duong, D. M.; Cudkowicz, M.; Glass, J. D.; Peng, J. Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach. J. Proteome Res., 2010, 9, 5133-5141.
22. Wuolikainen, A.; Moritz, T.; Marklund, S. L.; Antti, H.; Andersen, P. M. Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS. PLoS One, 2011, 6, e17947.
23. Malaspina, A.; Kaushik, N.; de Belleroche, J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J. Neurochem., 2001, 77, 132-145.
24. Ishigaki, S.; Niwa, J.; Ando, Y.; Yoshihara, T.; Sawada, K.; Doyu, M.; Yamamoto, M.; Kato, K.; Yotsumoto, Y.; Sobue, G. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords--screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett., 2002, 531, 354-358.
25. Olsen, M. K.; Roberds, S. L.; Ellerbrock, B. R.; Fleck, T. J.; McKinley, D. K.; Gurney, M. E. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann. Neurol., 2001, 50, 730-740.
26. Igaz, L. M.; Kwong, L. K.; Lee, E. B.; Chen-Plotkin, A.; Swanson, E.; Unger, T.; Malunda, J.; Xu, Y.; Winton, M. J.; Trojanowski, J. Q.; Lee, V. M. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J. Clin. Invest., 2011, 121, 726-738.
27. Shtilbans, A.; Choi, S. G.; Fowkes, M. E.; Khitrov, G.; Shahbazi, M.; Ting, J.; Zhang, W.; Sun, Y.; Sealfon, S. C.; Lange, D. J. Differential gene expression in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler., 2011.
28. Dangond, F.; Hwang, D.; Camelo, S.; Pasinelli, P.; Frosch, M. P.; Stephanopoulos, G.; Brown, R. H., Jr.; Gullans, S. R. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol. Genomics, 2004, 16, 229-239.
29. Jiang, Y. M.; Yamamoto, M.; Kobayashi, Y.; Yoshihara, T.; Liang, Y.; Terao, S.; Takeuchi, H.; Ishigaki, S.; Katsuno, M.; Adachi, H.; Niwa, J.; Tanaka, F.; Doyu, M.; Yoshida, M.; Hashizume, Y.; Sobue, G. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol., 2005, 57, 236-251.
30. Gonzalez de Aguilar, J. L.; Niederhauser-Wiederkehr, C.; Halter, B.; De Tapia, M.; Di Scala, F.; Demougin, P.; Dupuis, L.; Primig, M.; Meininger, V.; Loeffler, J. P. Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol. Genomics, 2008, 32, 207-218.
31. Kudo, L. C.; Parfenova, L.; Vi, N.; Lau, K.; Pomakian, J.; Valdmanis, P.; Rouleau, G. A.; Vinters, H. V.; Wiedau-Pazos, M.; Karsten, S. L. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Hum. Mol. Genet., 2010, 19, 3233-3253.
32. Malaspina, A.; Ngoh, S. F.; Ward, R. E.; Hall, J. C.; Tai, F. W.; Yip, P. K.; Jones, C.; Jokic, N.; Averill, S. A.; Michael-Titus, A. T.; Priestley, J. V. Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis. Neuroscience, 2010, 169, 812-827.
33. Lederer, C. W.; Torrisi, A.; Pantelidou, M.; Santama, N.; Cavallaro, S. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics, 2007, 8, 26.
34. Wang, X. S.; Simmons, Z.; Liu, W.; Boyer, P. J.; Connor, J. R. Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex. Amyotroph. Lateral Scler., 2006, 7, 201-210.
35. Kirby, J.; Ning, K.; Ferraiuolo, L.; Heath, P. R.; Ismail, A.; Kuo, S. W.; Valori, C. F.; Cox, L.; Sharrack, B.; Wharton, S. B.; Ince, P. G.; Shaw, P. J.; Azzouz, M. Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain, 2011, 134, 506-517.
36. Offen, D.; Barhum, Y.; Melamed, E.; Embacher, N.; Schindler, C.; Ransmayr, G. Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant. J. Mol. Neurosci., 2009, 38, 85-93.
37. Dupuis, L.; Corcia, P.; Fergani, A.; Gonzalez De Aguilar, J. L.; Bonnefont-Rousselot, D.; Bittar, R.; Seilhean, D.; Hauw, J. J.; Lacomblez, L.; Loeffler, J. P.; Meininger, V. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology, 2008, 70, 1004-1009.
38. Laird, F. M.; Farah, M. H.; Ackerley, S.; Hoke, A.; Maragakis, N.; Rothstein, J. D.; Griffin, J.; Price, D. L.; Martin, L. J.; Wong, P. C. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking. J. Neurosci., 2008, 28, 1997-2005.
39. Munch, C.; Rosenbohm, A.; Sperfeld, A. D.; Uttner, I.; Reske, S.; Krause, B. J.; Sedlmeier, R.; Meyer, T.; Hanemann, C. O.; Stumm, G.; Ludolph, A. C. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann. Neurol., 2005, 58, 777-780.
40. Mackenzie, I. R.; Rademakers, R.; Neumann, M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol., 2010, 9, 995-1007.
41. Gurney, M. E.; Pu, H.; Chiu, A. Y.; Dal Canto, M. C.; Polchow, C. Y.; Alexander, D. D.; Caliendo, J.; Hentati, A.; Kwon, Y. W.; Deng, H. X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 1994, 264, 1772-1775.
42. D'Arrigo, A.; Colavito, D.; Pena-Altamira, E.; Fabris, M.; Dam, M.; Contestabile, A.; Leon, A. Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease? J. Mol. Neurosci., 2010, 41, 404-415.
43. Yoshihara, T.; Ishigaki, S.; Yamamoto, M.; Liang, Y.; Niwa, J.; Takeuchi, H.; Doyu, M.; Sobue, G. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem., 2002, 80, 158-167.
44. Ferraiuolo, L.; Heath, P. R.; Holden, H.; Kasher, P.; Kirby, J.; Shaw, P. J. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J. Neurosci., 2007, 27, 9201-9219.
45. Perrin, F. E.; Boisset, G.; Docquier, M.; Schaad, O.; Descombes, P.; Kato, A. C. No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model. Hum. Mol. Genet., 2005, 14, 3309-3320.
46. Shim, S. Y.; Samuels, B. A.; Wang, J.; Neumayer, G.; Belzil, C.; Ayala, R.; Shi, Y.; Tsai, L. H.; Nguyen, M. D. Ndel1 controls the dynein-mediated transport of vimentin during neurite outgrowth. J. Biol. Chem., 2008, 283, 12232-12240.
47. Chen, H.; Guo, Y.; Hu, M.; Duan, W.; Chang, G.; Li, C. Differential expression and alternative splicing of genes in lumbar spinal cord of an amyotrophic lateral sclerosis mouse model. Brain Res., 2010, 1340, 52-69.
48. Boutahar, N.; Wierinckx, A.; Camdessanche, J. P.; Antoine, J. C.; Reynaud, E.; Lassabliere, F.; Lachuer, J.; Borg, J. Differential effect of oxidative or excitotoxic stress on the transcriptional profile of amyotrophic lateral sclerosis-linked mutant SOD1 cultured neurons. J. Neurosci. Res., 2011.
49. Vargas, M. R.; Pehar, M.; Diaz-Amarilla, P. J.; Beckman, J. S.; Barbeito, L. Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1. J. Neurosci. Res., 2008, 86, 3515-3525.
50. Kirby, J.; Halligan, E.; Baptista, M. J.; Allen, S.; Heath, P. R.; Holden, H.; Barber, S. C.; Loynes, C. A.; Wood-Allum, C. A.; Lunec, J.; Shaw, P. J. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain, 2005, 128, 1686-1706.
51. Lenzken, S. C.; Romeo, V.; Zolezzi, F.; Cordero, F.; Lamorte, G.; Bonanno, D.; Biancolini, D.; Cozzolino, M.; Pesaresi, M. G.; Maracchioni, A.; Sanges, R.; Achsel, T.; Carri, M. T.; Calogero, R. A.; Barabino, S. M. Mutant SOD1 and mitochondrial damage alter expression and splicing of genes controlling neuritogenesis in models of neurodegeneration. Hum. Mutat., 2011, 32, 168-182.
52. Jokic, N.; Yip, P. K.; Michael-Titus, A.; Priestley, J. V.; Malaspina, A. The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compression. BMC Genomics, 2010, 11, 633.
53. Watanabe, Y.; Yasui, K.; Nakano, T.; Doi, K.; Fukada, Y.; Kitayama, M.; Ishimoto, M.; Kurihara, S.; Kawashima, M.; Fukuda, H.; Adachi, Y.; Inoue, T.; Nakashima, K. Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification. Brain Res. Mol. Brain Res., 2005, 135, 12-20.
54. Fukada, Y.; Yasui, K.; Kitayama, M.; Doi, K.; Nakano, T.; Watanabe, Y.; Nakashima, K. Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1. Brain Res., 2007, 1160, 1-10.
55. Dobrowolny, G.; Aucello, M.; Rizzuto, E.; Beccafico, S.; Mammucari, C.; Boncompagni, S.; Belia, S.; Wannenes, F.; Nicoletti, C.; Del Prete, Z.; Rosenthal, N.; Molinaro, M.; Protasi, F.; Fano, G.; Sandri, M.; Musaro, A. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab., 2008, 8, 425-436.
56. Dupuis, L.; Gonzalez de Aguilar, J. L.; Echaniz-Laguna, A.; Eschbach, J.; Rene, F.; Oudart, H.; Halter, B.; Huze, C.; Schaeffer, L.; Bouillaud, F.; Loeffler, J. P. Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One, 2009, 4, e5390.
57. Ripps, M. E.; Huntley, G. W.; Hof, P. R.; Morrison, J. H.; Gordon, J. W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA, 1995, 92, 689-693.
58. Brockington, A.; Heath, P. R.; Holden, H.; Kasher, P.; Bender, F. L.; Claes, F.; Lambrechts, D.; Sendtner, M.; Carmeliet, P.; Shaw, P. J. Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFdelta/delta mouse model of amyotrophic lateral sclerosis. BMC Genomics, 2010, 11, 203.
59. Chio, A.; Benzi, G.; Dossena, M.; Mutani, R.; Mora, G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain, 2005, 128, 472-476.
60. Deforges, S.; Branchu, J.; Biondi, O.; Grondard, C.; Pariset, C.; Lecolle, S.; Lopes, P.; Vidal, P. P.; Chanoine, C.; Charbonnier, F. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J. Physiol., 2009, 587, 3561-3572.
61. Ferraiuolo, L.; De Bono, J. P.; Heath, P. R.; Holden, H.; Kasher, P.; Channon, K. M.; Kirby, J.; Shaw, P. J. Transcriptional response of the neuromuscular system to exercise training and potential implications for ALS. J. Neurochem., 2009, 109, 1714-1724.
62. Hashimoto, K.; Honda, A.; Hayashi, Y.; Inuzuka, T.; Satoh, M.; Hozumi, I. DNA microarray analysis of transcriptional responses of mouse spinal cords to physical exercise. J. Toxicol. Sci., 2009, 34, 445-448.
63. Nimchinsky, E. A.; Young, W. G.; Yeung, G.; Shah, R. A.; Gordon, J. W.; Bloom, F. E.; Morrison, J. H.; Hof, P.R. Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice. J. Comp. Neurol., 2000, 416, 112-125.
64. Hedlund, E.; Karlsson, M.; Osborn, T.; Ludwig, W.; Isacson, O. Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection. Brain, 2010, 133, 2313-2330.
65. Xiao, S.; Tjostheim, S.; Sanelli, T.; McLean, J. R.; Horne, P.; Fan, Y.; Ravits, J.; Strong, M. J.; Robertson, J. An aggregate-inducing peripherin isoform generated through intron retention is upregulated in amyotrophic lateral sclerosis and associated with disease pathology. J. Neurosci., 2008, 28, 1833-1840.
66. Saris, C. G.; Horvath, S.; van Vught, P. W.; van Es, M. A.; Blauw, H. M.; Fuller, T. F.; Langfelder, P.; DeYoung, J.; Wokke, J. H.; Veldink, J. H.; van den Berg, L. H.; Ophoff, R. A. Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients. BMC Genomics, 2009, 10, 405.
67. Zhang, R.; Hadlock, K. G.; Do, H.; Yu, S.; Honrada, R.; Champion, S.; Forshew, D.; Madison, C.; Katz, J.; Miller, R. G.; McGrath, M. S. Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol., 2011, 230, 114-123.
68. Lewis, J.; McGowan, E.; Rockwood, J.; Melrose, H.; Nacharaju, P.; Van Slegtenhorst, M.; Gwinn-Hardy, K.; Paul Murphy, M.; Baker, M.; Yu, X.; Duff, K.; Hardy, J.; Corral, A.; Lin, W. L.; Yen, S. H.; Dickson, D. W.; Davies, P.; Hutton, M. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet., 2000, 25, 402-405.
69. Pradat, P. F.; Dubourg, O.; De Tapia, M.; Di Scala, F.; Dupuis, L.; Lenglet, T.; Bruneteau, G.; Salachas, F.; Lacomblez, L.; Corvol, J.-C.; Demougin, P.; Primig, M.; Meininger, V.; Loeffler, J. P.; Gonzalez de Aguilar, J. L. Muscle Gene Expression Is a Marker of Amyotrophic Lateral Sclerosis Severity. Neurodegener. Dis., 2011, DOI: 10.1159/000329723.
70. Cox, L. E.; Ferraiuolo, L.; Goodall, E. F.; Heath, P. R.; Higginbottom, A.; Mortiboys, H.; Hollinger, H. C.; Hartley, J. A.; Brockington, A.; Burness, C. E.; Morrison, K. E.; Wharton, S. B.; Grierson, A. J.; Ince, P. G.; Kirby, J.; Shaw, P. J. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS One, 2010, 5, e9872.
71. Fiala, M.; Chattopadhay, M.; La Cava, A.; Tse, E.; Liu, G.; Lourenco, E.; Eskin, A.; Liu, P. T.; Magpantay, L.; Tse, S.; Mahanian, M.; Weitzman, R.; Tong, J.; Nguyen, C.; Cho, T.; Koo, P.; Sayre, J.; Martinez-Maza, O.; Rosenthal, M. J.; Wiedau-Pazos, M. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. J. Neuroinflammation, 2011, 7, 76.
72. Huang, C.; Zhou, H.; Tong, J.; Chen, H.; Liu, Y. J.; Wang, D.; Wei, X.; Xia, X. G. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. PLoS Genet., 2011, 7, e1002011.
73. Levy, J. R.; Sumner, C. J.; Caviston, J. P.; Tokito, M. K.; Ranganathan, S.; Ligon, L. A.; Wallace, K. E.; LaMonte, B. H.; Harmison, G. G.; Puls, I.; Fischbeck, K. H.; Holzbaur, E. L. A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation. J. Cell Biol., 2006, 172, 733-745.
74. McCombe, P. A.; Henderson, R. D. The Role of immune and inflammatory mechanisms in ALS. Curr. Mol. Med., 2011, 11, 246-254.
75. Marcuzzo, S.; Zucca, I.; Mastropietro, A.; de Rosbo, N. K.; Cavalcante, P.; Tartari, S.; Bonanno, S.; Preite, L.; Mantegazza, R.; Bernasconi, P. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: A longitudinal MRI study. Exp. Neurol., 2011.
76. Cruts, M.; Gijselinck, I.; van der Zee, J.; Engelborghs, S.; Wils, H.; Pirici, D.; Rademakers, R.; Vandenberghe, R.; Dermaut, B.; Martin, J. J.; van Duijn, C.; Peeters, K.; Sciot, R.; Santens, P.; De Pooter, T.; Mattheijssens, M.; Van den Broeck, M.; Cuijt, I.; Vennekens, K.; De Deyn, P. P.; Kumar-Singh, S.; Van Broeckhoven, C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature, 2006, 442, 920-924.